Milestone Pharmaceuticals Inc. MIST
MIST
Milestone Pharmaceuticals Inc. RANI
Rani Therapeutics Holdings, Inc. MOLN
Molecular Partners AG APLT
Applied Therapeutics, Inc. CRDF
Cardiff Oncology, Inc. ELTX
Elicio Therapeutics, Inc. CYBN
Cybin Inc. IPHA
Innate Pharma S.A. CRBP
Corbus Pharmaceuticals Holdings, Inc. SAVA
Cassava Sciences, Inc.
Milestone Pharmaceuticals Inc. RANI
Rani Therapeutics Holdings, Inc. MOLN
Molecular Partners AG APLT
Applied Therapeutics, Inc. CRDF
Cardiff Oncology, Inc. ELTX
Elicio Therapeutics, Inc. CYBN
Cybin Inc. IPHA
Innate Pharma S.A. CRBP
Corbus Pharmaceuticals Holdings, Inc. SAVA
Cassava Sciences, Inc.
Performance
| Periode | MIST | RANI | MOLN | APLT | CRDF | ELTX | CYBN | IPHA | CRBP | SAVA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 37.88 % | 174.11 % | 4.17 % | -68.45 % | -36.35 % | 14.52 % | -19.16 % | -2.89 % | 7.93 % | 36.90 % |
| YTD | 4.84 % | -1.38 % | -17.86 % | -87.56 % | -43.08 % | 69.33 % | -28.27 % | -1.34 % | -20.85 % | 2.05 % |
| 1Y | 27.09 % | -9.44 % | -25.23 % | -90.29 % | -39.83 % | 77.26 % | -31.89 % | -22.15 % | -33.26 % | 5.51 % |
| 3Y | -40.13 % | -82.00 % | -41.52 % | -86.94 % | 73.21 % | 47.77 % | -40.42 % | -16.14 % | 156.18 % | -50.33 % |
| 5Y | -68.96 % | -86.91 % | -79.64 % | -99.53 % | -88.25 % | 47.77 % | -89.85 % | -56.79 % | -76.47 % | 144.04 % |
| 10Y | -85.20 % | -86.91 % | -79.64 % | -98.81 % | -99.39 % | 47.77 % | -99.70 % | -69.50 % | -80.15 % | 50.89 % |
| From the beginning | -85.20 % | -86.91 % | -79.64 % | -98.81 % | -99.85 % | 47.77 % | -99.70 % | -69.50 % | -89.41 % | -87.17 % |